Dihydroartemisinin's Role in Targeting Lung Cancer Metastasis

Impact of Macrophage Polarization on Tumor Progression

Macrophages are crucial components of the immune system and play a pivotal role in tumor progression. They can be polarized into two primary phenotypes: M1 macrophages, which exhibit pro-inflammatory properties and can suppress tumor growth, and M2 macrophages, which support tumor progression by promoting angiogenesis, tissue remodeling, and immune suppression. The balance between these two phenotypes significantly influences the outcomes of cancer therapies and the overall progression of tumors.

Research indicates that an increased presence of M2 macrophages is often associated with poor prognosis in various cancers, including lung cancer. This shift in macrophage polarization is primarily driven by the tumor microenvironment, which secretes factors like CCL2 that attract monocytes and promote their differentiation into M2 macrophages. Consequently, targeting macrophage polarization has emerged as a promising therapeutic strategy to inhibit tumor growth and metastasis.

Mechanisms of Dihydroartemisinin in Regulating Macrophages

DHA has been identified as a potent agent that can modulate macrophage polarization. Studies have shown that DHA inhibits the M2 polarization of macrophages while promoting M1 polarization. This effect is mediated through several mechanisms, including the downregulation of M2-related markers such as CD206 and the upregulation of M1-associated cytokines such as IL-12 and TNF-α.

In vitro studies have demonstrated that DHA affects the secretion of various cytokines by influencing macrophage behavior. For instance, treatments with DHA resulted in decreased levels of anti-inflammatory cytokines associated with M2 macrophages and increased levels of pro-inflammatory cytokines linked to M1 macrophages. This reprogramming of macrophages from a pro-tumor to an anti-tumor phenotype is crucial in curbing the growth and metastasis of lung cancer cells.

Additionally, DHA has been shown to inhibit the recruitment of macrophages to tumor sites through the CCL2/CCR2 signaling pathway. By decreasing the levels of CCL2, DHA effectively reduces the accumulation of macrophages in the tumor microenvironment, thereby limiting their supportive role in tumor progression.

Clinical Implications of Dihydroartemisinin in Cancer Therapy

The promising results observed in preclinical studies underscore the potential of DHA as a therapeutic agent in lung cancer treatment. By targeting macrophage polarization and inhibiting tumor growth and metastasis, DHA may complement existing therapies, improving patient outcomes. Clinical trials investigating the efficacy of DHA in combination with standard chemotherapeutic agents are warranted to further establish its role in cancer therapy.

Given the significant impact of macrophage polarization on tumor dynamics, the incorporation of DHA into treatment regimens could enhance the anti-tumor immune response. Moreover, understanding the specific molecular mechanisms by which DHA exerts its effects will be critical in optimizing its use in clinical settings.

Future Directions for Dihydroartemisinin Research in Oncology

Future research should focus on elucidating the precise molecular mechanisms underlying DHA’s anti-cancer effects, particularly its role in regulating macrophage polarization. Additionally, large-scale clinical trials are needed to evaluate the safety and efficacy of DHA in various cancer types, including lung cancer. Investigating potential synergistic effects when combined with other therapeutic agents could lead to more effective treatment protocols, ultimately improving survival rates for cancer patients.

Furthermore, the exploration of DHA’s effects on other components of the tumor microenvironment, such as T cells and fibroblasts, may provide a more comprehensive understanding of its therapeutic potential. Overall, DHA represents a promising avenue in the fight against cancer, warranting further investigation and development.

FAQ

What is Dihydroartemisinin (DHA)?

Dihydroartemisinin (DHA) is a derivative of artemisinin, a compound extracted from the sweet wormwood plant, traditionally used in Chinese medicine for treating malari

How does DHA affect macrophage polarization?

DHA inhibits M2 polarization and promotes M1 polarization of macrophages, which can help suppress tumor growth and metastasis in cancers like lung cancer.

What are M1 and M2 macrophages?

M1 macrophages are pro-inflammatory and help in anti-tumor activities, while M2 macrophages are anti-inflammatory and promote tumor progression.

What is the significance of macrophage polarization in cancer?

The polarization of macrophages significantly influences tumor progression, response to therapies, and overall patient prognosis.

Are there clinical trials investigating DHA for cancer treatment?

Yes, ongoing research and clinical trials are needed to establish the efficacy and safety of DHA as a therapeutic agent in cancer treatment.

References

1. Tavassoli, A., & McDermott, A. (2024). Hypoxia-inducible transcription factors: architects of tumorigenesis and targets for anticancer drug discovery. Transcription, 15(1), 1-17
2. Jiang, Z., et al. (2025). Germline variants analysis of Chinese breast cancer patients reveals numerous alterations in homologous recombination genes. Future Science OA
3. Nazmabadi, R., et al. (2024). Dihydroartemisinin enhances the therapeutic efficacy of BH3 mimetic inhibitor in acute lymphoblastic leukemia cells via inhibition of Mcl-1. Asian Pacific Journal of Cancer Prevention, 25, 325-332. https://doi.org/10.31557/APJCP.2024.25.1.325
4. Zhao, L., et al. (2025). Factors associated with declining cytoreductive surgery in advanced epithelial ovarian cancer: a population-based study. World Journal of Surgical Oncology, 21(1), 1-12. https://doi.org/10.1186/s12957-025-03769-3
5. Diao, Y., et al. (2024). CCL2 promotes metastasis and epithelial-mesenchymal transition of non-small cell lung cancer via PI3K/Akt/mTOR and autophagy pathways. Cell Prolif, 57(3), e13560
6. Guihua, H., et al. (2025). Dihydroartemisinin inhibits lung cancer bone metastasis by modulating macrophage polarization. Medical Oncology, 42(1). https://doi.org/10.1186/s40001-025-02467-w
7. Curcumin, L., et al. (2025). Curcumin suppresses malignant behaviors of ovarian cancer through regulation of tumor-associated macrophages. Medical Oncology, 42(1). https://doi.org/10.1007/s12032-025-02682-9
8. Blakely, C. M., et al. (2024). Circulating Tumour DNA in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer and Early Disease Progression After First-Line Osimertinib Treatment: The ELUCIDATOR Multicentre Prospective Observational Study. Medical Oncology. https://doi.org/10.1007/s12032-025-02682-9